Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Kazumasa Hasegawa"'
Autor:
Beverly A. Teicher, Glenn Miller, Bruce Horten, Khodadad Mehraein, Beth L. Thurberg, Shiro Kataoka, Isao Ishida, Kazumasa Hasegawa, Nakayuki Honma, Rebecca Bagley, Gina Wallar, Carol Berger, James Mascarello, Leslie Kurtzberg, Robert Smale, William Weber, Maritza Curiel, Cecile Rouleau
Purpose: Endosialin/CD248/tumor endothelial marker 1 is expressed in stromal cells, endothelial cells, and pericytes in various tumors; however, few studies have focused on expression in malignant cells.Experimental Design: We studied expression of e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6be12cf58f27425798d7cdb94094a1a3
https://doi.org/10.1158/1078-0432.c.6517080
https://doi.org/10.1158/1078-0432.c.6517080
Autor:
Beverly A. Teicher, Glenn Miller, Bruce Horten, Khodadad Mehraein, Beth L. Thurberg, Shiro Kataoka, Isao Ishida, Kazumasa Hasegawa, Nakayuki Honma, Rebecca Bagley, Gina Wallar, Carol Berger, James Mascarello, Leslie Kurtzberg, Robert Smale, William Weber, Maritza Curiel, Cecile Rouleau
Supplementary Data from Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e766b31f41cf854afd8317a571b542
https://doi.org/10.1158/1078-0432.22439643.v1
https://doi.org/10.1158/1078-0432.22439643.v1
Autor:
Toshiyuki Isae, Masabumi Shibuya, Kinya Kubo, Rika Suzuki, Yasunari Fujiwara, Kazuo Kubo, Kazumasa Hasegawa, Nicolas Guilbaud, Francis Bichat, Kazumi Takahashi, Atsushi Yamamoto, Toru Miura, Eri Taguchi, Kazuhide Nakamura
Vascular endothelial growth factor (VEGF) plays a key role in tumor angiogenesis by stimulating the proangiogenic signaling of endothelial cells via activation of VEGF receptor (VEGFR) tyrosine kinases. Therefore, VEGFRs are an attractive therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7425b04994428348f885c719ee234b1f
https://doi.org/10.1158/0008-5472.c.6494259.v1
https://doi.org/10.1158/0008-5472.c.6494259.v1
Autor:
Toshiyuki Isae, Masabumi Shibuya, Kinya Kubo, Rika Suzuki, Yasunari Fujiwara, Kazuo Kubo, Kazumasa Hasegawa, Nicolas Guilbaud, Francis Bichat, Kazumi Takahashi, Atsushi Yamamoto, Toru Miura, Eri Taguchi, Kazuhide Nakamura
Supplementary Table 1 from KRN951, a Highly Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Has Antitumor Activities and Affects Functional Vascular Properties
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c76e1e571087f5887b568d44c13707f4
https://doi.org/10.1158/0008-5472.22364580.v1
https://doi.org/10.1158/0008-5472.22364580.v1
Autor:
Kazumasa HASEGAWA
Publikováno v:
JOURNAL OF THE JAPAN WELDING SOCIETY. 83:53-58
Autor:
Shiro Kataoka, Khodadad Mehraein, Leslie Kurtzberg, Kazumasa Hasegawa, Beth L. Thurberg, Carol Berger, Maritza Curiel, Gina Wallar, Isao Ishida, Beverly A. Teicher, Robert Smale, Bruce Horten, Nakayuki Honma, Cecile Rouleau, James Mascarello, Rebecca G. Bagley, William Weber, Glenn Miller
Publikováno v:
Clinical Cancer Research. 14:7223-7236
Purpose: Endosialin/CD248/tumor endothelial marker 1 is expressed in stromal cells, endothelial cells, and pericytes in various tumors; however, few studies have focused on expression in malignant cells. Experimental Design: We studied expression of
Autor:
Ayami, Yamaguchi, Katsuaki, Usami, Munetake, Shimabe, Kazumasa, Hasegawa, Masao, Asada, Kazuhiro, Motoki, Tomoyuki, Tahara, Kazuhiro, Masuda
Publikováno v:
Anticancer research. 35(4)
Carbonic anhydrase IX (CA IX) is an attractive target for cancer therapy. Many anti-CA IX antibodies have been reported but few have been shown to possess inhibition activity. Furthermore, effective use of CA IX-inhibition antibodies for cancer immun
Autor:
Masabumi Shibuya, Kazumi Takahashi, Toru Miura, Kazuhide Nakamura, Kazuo Kubo, Kinya Kubo, Atsushi Yamamoto, Toshiyuki Isae, Francis Bichat, Kazumasa Hasegawa, Eri Taguchi, Yasunari Fujiwara, Rika Suzuki, Nicolas Guilbaud
Publikováno v:
Cancer Research. 66:9134-9142
Vascular endothelial growth factor (VEGF) plays a key role in tumor angiogenesis by stimulating the proangiogenic signaling of endothelial cells via activation of VEGF receptor (VEGFR) tyrosine kinases. Therefore, VEGFRs are an attractive therapeutic
Autor:
Kazuhide Nakamura, Kazumasa Hasegawa, Hideko Murooka, Shinichiro Kato, Toshiyuki Shimizu, Yoshiko Kobayashi, Toshiyuki Isoe, Noriko Takahashi, Kazumi Takahashi, Shinichi Ohyama, Kazuo Kubo, Toshio Izawa, Akemi Iwai
Publikováno v:
Journal of Medicinal Chemistry. 48:1359-1366
N-Phenyl-N'-{4-(4-quinolyloxy)phenyl}ureas were found to be a novel class of potent inhibitors for the vascular endothelial growth factor receptor 2 (VEGFR-2) tyrosine kinase through synthetic modifications of a lead compound and structure-activity r
Autor:
Kenichi Muraoka, Satoshi Yoshida, Kazumasa Hasegawa, Nobuo Nakanishi, Isao Fukuzawa, Akio Tomita, Jong Chol Cyong
Publikováno v:
The Journal of Alternative and Complementary Medicine. 10:841-849